DS
PKBO

David Shaw’s Peak Bio, Inc. Common Stock PKBO Stock Holding History

David Shaw’s Portfolio PKBO Stock Details PKBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-193,366
Closed -$1.93M – 5348
2022
Q3 		$1.93M Hold
193,366
– – ﹤0.01% 3044
2022
Q2 		$1.91M Hold
193,366
– – ﹤0.01% 3115
2022
Q1 		$1.9M Buy
193,366
+82,560
+75% +$810K ﹤0.01% 3344
2021
Q4 		$1.08M Buy
110,806
+76,407
+222% +$747K ﹤0.01% 3865
2021
Q3 		$337K Buy
+34,399
New +$334K ﹤0.01% 4298

Other funds holding PKBO

PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

David Shaw's PKBO Position: Q4 2022 in Review

David Shaw sold out of Peak Bio, Inc. Common Stock (PKBO) in Q4 2022, closing a stake of 193,366 shares — an estimated $1.93M sold.

David Shaw first reported a position in PKBO in Q3 2021 and held it in 5 quarters. The position peaked at $1.93M in Q3 2022. 9 funds tracked by Wall St. Rank hold PKBO as of Q4 2022.

  • David Shaw reported no remaining Peak Bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • David Shaw sold 193,366 Peak Bio, Inc. Common Stock shares in Q4 2022, an estimated $1.93M.
  • David Shaw first reported a position in Peak Bio, Inc. Common Stock in Q3 2021 and held it in 5 quarters.
  • David Shaw's Peak Bio, Inc. Common Stock position peaked at $1.93M in Q3 2022.
  • 9 funds tracked by Wall St. Rank held Peak Bio, Inc. Common Stock as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.